Xerac Ac Liquid
FDA Label NDC 0096-0709

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Person And Covey for the product Xerac Ac (NDC 0096-0709). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - purpose section, dosage & administration section, warnings section, otc - keep out of reach of children section, otc - active ingredient section, inactive ingredient section, indicatins and usage section, principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Otc - Purpose Section

For topical application as an antiperspirant (anhidrotic).

Dosage & Administration Section

Xerac AC when applied to the underarms, should be applied to absolutely dry skin. Only apply Xerac AC before bedtime, since medication should be kept on the skin for 6-8 hours. To reduce irritation, let the alcohol evaporate, leaving a thin film of antiperspirant on the skin. Wear a T-shirt, while sleeping to prevent medication from being rubbed off on the bed linens. Do not apply Xerac AC to broken, irritated or recently shaved skin. Wash the treated area next morning with soap and water. Do not apply other deodorants or antiperspirants while using Xerac AC.

Warnings Section

For external use only. Avoid contact with eyes. If contact occurs, wash eyes thoroughly with water. If irritation or sensitization occurs, discontinue use or contact a physician. Xerac AC may be harmful to cotton fibers and certain metals.

Otc - Keep Out Of Reach Of Children Section

Yes. If swallowed, get medical help or contact a Poison Control Center right away.

Otc - Active Ingredient Section

Aluminum Chloride Hexahydrate

Inactive Ingredient Section

Anhydrous ethanol

* Please review the disclaimer below.